Suppliers / Công ty cổ phần dược phẩm Đạt Vi Phú

Công ty cổ phần dược phẩm Đạt Vi Phú

Vietnam Updated 9 July 2026

Công ty cổ phần dược phẩm Đạt Vi Phú (Địa chỉ: Lô M7A, Đường D17, Khu Công nghiệp Mỹ Phước 1, Phường Thới Hòa, Thị xã Bến Cát, Tỉnh Bình Dương, Việt Nam) is an API and finished-dose manufacturer based in Vietnam. It appears in 346 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
346
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Quetiapine DAV (Vietnam) 5
Isotretinoin DAV (Vietnam) 4
Rosuvastatin DAV (Vietnam) 4
Cilnidipine DAV (Vietnam) 3
Irbesartan DAV (Vietnam) 3
Levosulpiride DAV (Vietnam) 3
Losartan DAV (Vietnam) 3
Aceclofenac DAV (Vietnam) 2
Atorvastatin DAV (Vietnam) 2
Benazepril DAV (Vietnam) 2
Show all 30 molecules on file
Calcipotriol DAV (Vietnam) 2
Carvedilol DAV (Vietnam) 2
Cilostazol DAV (Vietnam) 2
Dapoxetine DAV (Vietnam) 2
Desloratadine DAV (Vietnam) 2
Gabapentin DAV (Vietnam) 2
Glucosamine DAV (Vietnam) 2
Methotrexate DAV (Vietnam) 2
Montelukast DAV (Vietnam) 2
Olanzapine DAV (Vietnam) 2
Pyridostigmine DAV (Vietnam) 2
Silver Sulfadiazine DAV (Vietnam) 2
Ursodeoxycholic Acid DAV (Vietnam) 2
Acarbose DAV (Vietnam) 1
Alendronat DAV (Vietnam) 1
Alendronic Acid DAV (Vietnam) 1
Alfuzosin DAV (Vietnam) 1
Allopurinol DAV (Vietnam) 1
Bambuterol DAV (Vietnam) 1
Bupropion DAV (Vietnam) 1

Also appears on these molecule pages

Acarbose finished dose Afatinib finished dose Bambuterol finished dose Benazepril finished dose Calcipotriol finished dose Dapoxetine finished dose Deferiprone finished dose Eperisone finished dose Flavoxate finished dose Flunarizine finished dose Hydroclorothiazide finished dose Loxoprofen finished dose
Show 27 more molecule pages
Milnacipran finished dose Penicillamine finished dose Propylthiouracil finished dose Pyridostigmine finished dose Rebamipid finished dose Sulpiride finished dose Tolvaptan finished dose Atorvastatin API Losartan API Rosuvastatin API Quetiapine API Carvedilol API Montelukast API Gabapentin API Ursodeoxycholic Acid API Desloratadine API Irbesartan API Allopurinol API Cilostazol API Isotretinoin API Alendronic Acid API Olanzapine API Bupropion API Methotrexate API Alfuzosin API Glucosamine API Silver Sulfadiazine API

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 346 None

Questions about Công ty cổ phần dược phẩm Đạt Vi Phú

Does Công ty cổ phần dược phẩm Đạt Vi Phú hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Công ty cổ phần dược phẩm Đạt Vi Phú. It does have 346 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
What does Công ty cổ phần dược phẩm Đạt Vi Phú make?
30 molecules are on record against Công ty cổ phần dược phẩm Đạt Vi Phú, including Quetiapine, Isotretinoin, Rosuvastatin and Cilnidipine. Each links through to that molecule's full manufacturer list.
Where does Công ty cổ phần dược phẩm Đạt Vi Phú file?
Filings are on record with DAV (Vietnam), 346 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Công ty cổ phần dược phẩm Đạt Vi Phú?

Ask Fred what the record holds on Công ty cổ phần dược phẩm Đạt Vi Phú, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Danapha Pharmaceutical Joint Stock also in Vietnam Fremed Pharmaceutical Joint Stock also in Vietnam Hanoi Cpc1 Pharmaceutical Joint Stock also in Vietnam Imexpharm also in Vietnam Minh also in Vietnam

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability